Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

We previously identified an extracellular matrix (ECM) gene expression pattern in breast cancer (BC), called ECM3, characterized by a high expression of genes encoding structural ECM proteins. Since ECM is reportedly implicated in response to therapy of BCs, the aim of this work is to investigate th...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cells
Κύριοι συγγραφείς: Rybinska, Ilona, Sandri, Marco, Bianchi, Francesca, Orlandi, Rosaria, De Cecco, Loris, Gasparini, Patrizia, Campiglio, Manuela, Paolini, Biagio, Sfondrini, Lucia, Tagliabue, Elda, Triulzi, Tiziana
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: MDPI 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072535/
https://ncbi.nlm.nih.gov/pubmed/32069815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9020434
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια